How treatment delay may lead to loss of effectiveness of tranexamic acid

ANZ J Surg. 2020 Apr;90(4):416-418. doi: 10.1111/ans.15669.
No abstract available

MeSH terms

  • Antifibrinolytic Agents* / therapeutic use
  • Blood Loss, Surgical
  • Humans
  • Time-to-Treatment
  • Tranexamic Acid* / therapeutic use
  • Treatment Outcome

Substances

  • Antifibrinolytic Agents
  • Tranexamic Acid